Non-communicable respiratory disease and air pollution exposure in Malawi: a prospective cohort study.


Journal

Thorax
ISSN: 1468-3296
Titre abrégé: Thorax
Pays: England
ID NLM: 0417353

Informations de publication

Date de publication:
03 2020
Historique:
received: 09 08 2019
revised: 09 12 2019
accepted: 06 01 2020
pubmed: 23 2 2020
medline: 6 8 2020
entrez: 22 2 2020
Statut: ppublish

Résumé

There are no population-based studies from sub-Saharan Africa describing longitudinal lung function in adults. To explore the lung function trajectories and their determinants, including the effects of air pollution exposures and the cleaner-burning biomass-fuelled cookstove intervention of the Cooking and Pneumonia Study (CAPS), in adults living in rural Malawi. We assessed respiratory symptoms and exposures, spirometry and measured 48-hour personal exposure to fine particulate matter (PM We recruited 1481 adults, mean (SD) age 43.8 (17.8) years, including 523 participants from CAPS households (271 intervention; 252 controls), and collected multiple spirometry and air pollution measurements for 654 (44%) and 929 (63%), respectively. Compared with Global Lung Function Initiative African-American reference ranges, mean (SD) FEV We did not observe accelerated lung function decline in this cohort of Malawian adults, compared with that reported in healthy, non-smoking populations from high-income countries; this suggests that the lung function deficits we measured in adulthood may have origins in early life.

Identifiants

pubmed: 32079666
pii: thoraxjnl-2019-213941
doi: 10.1136/thoraxjnl-2019-213941
pmc: PMC7063402
doi:

Substances chimiques

Particulate Matter 0
Carbon Monoxide 7U1EE4V452

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

220-226

Subventions

Organisme : Medical Research Council
ID : MR/K006533/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L002515/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P022006/1
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Am J Respir Crit Care Med. 2017 Sep 12;197(5):595-610
pubmed: 28895752
Thorax. 2010 Nov;65(11):1010-5
pubmed: 20871124
Am J Respir Crit Care Med. 2009 Oct 1;180(7):649-56
pubmed: 19556519
Thorax. 2014 May;69(5):465-73
pubmed: 24353008
PLoS One. 2017 Sep 13;12(9):e0184530
pubmed: 28902919
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Thorax. 2019 Nov;74(11):1070-1077
pubmed: 31467192
Am J Epidemiol. 2009 Jul 15;170(2):211-20
pubmed: 19443665
Am J Respir Crit Care Med. 2019 Mar 1;199(5):613-621
pubmed: 30141966
PLoS One. 2017 Dec 7;12(12):e0188437
pubmed: 29216193
COPD. 2005 Jun;2(2):277-83
pubmed: 17136954
Environ Health Perspect. 2015 Apr;123(4):285-92
pubmed: 25398189
Lancet Respir Med. 2015 Feb;3(2):159-170
pubmed: 25680912
Eur Respir J. 2015 Jan;45(1):38-50
pubmed: 25193994
Ann Am Thorac Soc. 2017 May;14(5):714-721
pubmed: 28244800
Croat Med J. 2013 Dec;54(6):519-31
pubmed: 24382846
Am J Respir Crit Care Med. 2015 Mar 15;191(6):656-64
pubmed: 25590631
Lancet. 2017 Jan 14;389(10065):167-175
pubmed: 27939058
Int J Tuberc Lung Dis. 2015 Jan;19(1):10-20
pubmed: 25519785
Lancet Planet Health. 2018 Mar;2(3):e114-e125
pubmed: 29615226
Am J Respir Crit Care Med. 2018 Mar 1;197(5):611-620
pubmed: 29323928
Lancet Respir Med. 2014 Oct;2(10):823-60
pubmed: 25193349
Am J Respir Crit Care Med. 2016 Jul 1;194(1):67-76
pubmed: 26788760
Lancet Glob Health. 2015 Feb;3(2):e95-e103
pubmed: 25617203
Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):381-90
pubmed: 10673175
Am J Respir Crit Care Med. 2019 Mar 15;199(6):738-746
pubmed: 30256656
Environ Res. 2015 Oct;142:424-31
pubmed: 26245367
BMJ. 1991 Sep 21;303(6804):671-5
pubmed: 1912913
Ann Am Thorac Soc. 2017 May;14(5):624-625
pubmed: 28459627
N Engl J Med. 2015 Jul 9;373(2):111-22
pubmed: 26154786
Am J Respir Crit Care Med. 1999 Jan;159(1):179-87
pubmed: 9872837
Thorax. 1997 Sep;52(9):820-7
pubmed: 9371217
Eur Respir J. 2012 Dec;40(6):1324-43
pubmed: 22743675

Auteurs

Sarah Rylance (S)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Lung Health Group, Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

Chris Jewell (C)

CHICAS, University of Lancaster, Lancaster, UK.

Andrew Naunje (A)

Lung Health Group, Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

Frank Mbalume (F)

Lung Health Group, Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

John D Chetwood (JD)

John Hunter Hospital, New Lambton Heights, New South Wales, Australia.

Rebecca Nightingale (R)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.

Lindsay Zurba (L)

Education for Health Africa, Vereeniging, South Africa.

Graham Flitz (G)

School of Public Health, University of California, Berkeley, California, USA.

Stephen B Gordon (SB)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Lung Health Group, Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

Maia Lesosky (M)

Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Rondebosch, Cape Town, South Africa.

John R Balmes (JR)

School of Public Health, University of California, Berkeley, California, USA.
Environmental Health Sciences Division, University of California San Francisco, San Francisco, California, USA.

Kevin Mortimer (K)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK kevin.mortimer@lstmed.ac.uk.
Aintree University Hospitals NHS Foundation Trust, Liverpool, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH